Overview

Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections

Status:
Completed
Trial end date:
2015-03-03
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the safety and efficacy of isavuconazole versus caspofungin followed by voriconazole in the treatment of candidemia and other invasive Candida infections.
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Collaborator:
Basilea Pharmaceutica
Treatments:
Caspofungin
Echinocandins
Isavuconazole
Voriconazole